{"schema_version":"secwatch.filing_event.v1","accession":"0001753926-24-002047","form_type":"8-K","ticker":"LIPO","cik":"0001347242","company_name":"LIPELLA PHARMACEUTICALS INC.","filed_at":"2024-12-06T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.231468+00:00","generated_at":"2026-05-29T06:15:13.784159+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Lipella Pharmaceuticals special meeting adjourned due to lack of quorum; reconvenes Dec 20","bullets":["Lipella held special meeting Dec 6, 2024; no quorum present; meeting adjourned.","Reconvened special meeting set for Dec 20, 2024 at 2:00 p.m. ET.","Valid proxies from original meeting continue to apply unless changed or revoked.","Meeting related to proposals in Definitive Proxy Statement filed Nov 12, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001753926-24-002047","json":"https://secwatch.observer/filing/0001753926-24-002047.json","markdown":"https://secwatch.observer/filing/0001753926-24-002047.md","text":"https://secwatch.observer/filing/0001753926-24-002047.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002047/0001753926-24-002047-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1347242/000175392624002047/g084585_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T06:15:13.784159+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}